KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Share-based Compensation: 2017-2025

Historic Share-based Compensation for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $42.8 million.

  • Guardant Health's Share-based Compensation fell 13.99% to $42.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.4 million, marking a year-over-year increase of 24.17%. This contributed to the annual value of $140.4 million for FY2024, which is 54.71% up from last year.
  • As of Q3 2025, Guardant Health's Share-based Compensation stood at $42.8 million, which was up 0.81% from $42.5 million recorded in Q2 2025.
  • Guardant Health's Share-based Compensation's 5-year high stood at $55.1 million during Q1 2021, with a 5-year trough of $20.6 million in Q3 2022.
  • In the last 3 years, Guardant Health's Share-based Compensation had a median value of $27.2 million in 2024 and averaged $32.2 million.
  • Per our database at Business Quant, Guardant Health's Share-based Compensation skyrocketed by 768.87% in 2021 and then slumped by 54.97% in 2022.
  • Quarterly analysis of 5 years shows Guardant Health's Share-based Compensation stood at $26.9 million in 2021, then fell by 11.74% to $23.7 million in 2022, then rose by 2.60% to $24.3 million in 2023, then surged by 49.53% to $36.4 million in 2024, then dropped by 13.99% to $42.8 million in 2025.
  • Its Share-based Compensation was $42.8 million in Q3 2025, compared to $42.5 million in Q2 2025 and $37.8 million in Q1 2025.